Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Active not recruiting 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Breast Neoplasms 16Stomach Neoplasms 8Rectal Neoplasms 8Colorectal Neoplasms 7Triple Negative Breast Neoplasms 6Neoplasm Metastasis 6Adenocarcinoma Of Esophagus 6Adenocarcinoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 4Pancreatic Neoplasms 4Esophageal Neoplasms 4Nasopharyngeal Carcinoma 3Esophageal Squamous Cell Carcinoma 2Carcinoma 2Biliary Tract Neoplasms 2Anus Neoplasms 2Advanced Solid Tumour 2Solid Tumors 1Peritoneal Neoplasms 1Neoplasms 1HIV Infections 1HER2-positive Gastric Cancer 1HER2-positive Breast Cancer 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Clinical Stage I Gastric Cancer AJCC v8 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1Anal Canal Carcinoma 1

Interventions

Specimen Handling 20Gemcitabine 18Magnetic Resonance Spectroscopy 12Biopsy 12Leucovorin 10Irinotecan 10Fluorouracil 10130-nm albumin-bound paclitaxel 10Albumin-Bound Paclitaxel 8Oxaliplatin 7Taxes 6pembrolizumab 5Nivolumab 5irinotecan sucrosofate 4fludarabine 4dehydroftorafur 4Radiosurgery 4Ipilimumab 4Cyclophosphamide 4Capecitabine 4aldesleukin 3Radiotherapy 3Radiation 3Exercise 3Cisplatin 3Cetuximab 3veliparib 2trametinib 2quemliclustat 2palbociclib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Capecitabine × 30 days × Clear all
NCT01972919 2026-05-12

MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer

Medical College of Wisconsin

Phase 2 Active not recruiting
23 enrolled 8 charts
Gastrointestinal

Pancreatic Neoplasms

NCT05415917 2026-05-07

Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy

Rutgers, The State University of New Jersey

Phase 2 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT03523312 2026-05-06

MAIBE

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
47 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06958328 2026-05-04

LAP100

NRG Oncology

Phase 3 Recruiting
356 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡